Doctor profile · Federal record
Dr. Daniel Bruetman, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Chicago, IL
- NPI 1972583417
- Accepts Medicare
- MIPS 56.2 / 100 · 2023
- 43 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
Outpatient Care Center Downtown Chicago, 160 E. Illinois Street
Chicago, IL 60611
(312) 477-2400 - Additional location
-
4822 S Cottage Grove Ave Ste 5-100
Chicago, IL 60615
(866) 587-4322
fax (312) 921-1201
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- September 11, 2025
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- Indiana #01054353A · Illinois #036072153
- Medicaid
- IN #200316750
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972583417. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
102
Distinct HCPCS
4
Medicare allowed
$15,313
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 55 | 29 | $133 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 17 | 17 | $231 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 17 | 16 | $95 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 13 | 11 | $187 |
In context: peer comparison
Among 25 peers in Chicago Medical Oncology Physician, average services per provider: 1,025. This provider delivers 0.1× the peer median.Open Payments
Industry payments received
All-time total
$464
Transactions
18
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $137.74 | |
| Ipsen Biopharmaceuticals, INC | 1 | $69.99 | |
| Merck Sharp & Dohme LLC | 2 | $62.92 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $56.36 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $30.32 | |
| Genentech USA, INC. | 1 | $24.84 | |
| Gilead Sciences, INC. | 1 | $24.68 | |
| Astellas Pharma US INC | 1 | $23.51 | |
| Accord Healthcare, INC. | 1 | $17.09 | |
| Daiichi Sankyo INC. | 1 | $16.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
79
Patients
15
Total drug cost
$19,721
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 32 | 15 | $658 |
| Eliquis (Apixaban) | Brand | 23 | 0 | $17,938 |
| Hydroxyurea | Generic | 13 | 0 | $323 |
| Entecavir | Generic | 11 | 0 | $803 |
Frequently asked questions
What is Dr. Daniel Bruetman's medical specialty?
Dr. Daniel Bruetman practices Medical Oncology Physician in Chicago, IL.
Where does Dr. Daniel Bruetman practice?
Dr. Daniel Bruetman practices at Outpatient Care Center Downtown Chicago, Chicago, IL 60611. Office phone: 3124772400.
What is Dr. Daniel Bruetman's NPI?
Dr. Daniel Bruetman's National Provider Identifier (NPI) is 1972583417, issued by NPPES.
Does Dr. Daniel Bruetman accept Medicare assignment?
Yes. Dr. Daniel Bruetman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Bruetman commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99205); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.